Background
Methods
Participants and randomisation
Hypoxic group (n = 18) | Normoxic group (n = 16) | p-value | |
---|---|---|---|
Gender (m, f) | m 5 (28%) / f 13 (72%) | m 2 (12.5%) / f 14 (87.5%) | 0.25b |
Age (years) | 80.89 (7.87) | 83.44 (5.5) | 0.14 |
Height (cm) | 163.72 (8.29) | 163.19 (8.52) | 0.43 |
Weight (kg) | 72.03 (9.32) | 66.83 (12.27) | 0.09 |
BMI (kg/m2) | 26.98 (3.91) | 25.02 (3.62) | 0.07 |
MMSE score | 24.94 (3.75) | 24.5 (3.93) | 0.36 |
Therapy days (n) | 18.33 (2.43) | 17.5 (2.58) | 0.16c |
Arterial oxygen saturation (%) | 94.21 (6.19) | 93.65 (7.54) | 0.42 |
Minimum oxygen saturation (%)a | 81.39 (2.8) | 83.85 (5.51) | 0.27c |
Regular medication, n (%) | |||
Anticoagulants | 9 (50%) | 10 (62.5%) | 0.35b |
ß-blockers | 7 (38.9%) | 8 (50%) | 0.38b |
ACE inhibitors | 7 (38.9%) | 6 (37.5%) | 0.61b |
AT II inhibitors | 6 (33.3%) | 3 (18.8%) | 0.29b |
Calcium channel blockers | 5 (27.8%) | 1 (6.3%) | 0.12b |
Statins | 1 (5.6%) | 4 (25%) | 0.13b |
Diuretics | 8 (44.4%) | 9 (56.3%) | 0.37b |
Nitrates | 1 (5.6%) | 1 (6.3%) | 0.73b |
Study protocol
Multimodal training intervention (MTI)
Intermittent hypoxic–hyperoxic training (IHHT) programme
Assessments
Perceived health as a part of quality of life
Mobility
Cognitive testing
Evaluation of functional exercise capacity
Statistical methods
Results
Hypoxic group (n = 18) | Normoxic group (n = 16) | Hypoxic group (n = 18) | Normoxic group (n = 16) | p-value | |
---|---|---|---|---|---|
Pre Post | Pre Post | Delta Pre-Post | Delta Pre-Post | between groups | |
EQ-VAS (0–100) | 56.11 (11.95) 77.39 (11.1) | 52.38 (13.48) 70.13 (8.88) | + 21.28 (+ 37.9%) | + 17.75 (+ 33.9%) | 0.24 |
TMT (0–28) | 17.56 (6.08) 20.17 (4.88) | 18.19 (4.59) 21 (4.29) | + 2.61 (+ 14.9%) | + 2.81 (+ 15.4%) | 0.25 |
TUG (seconds) | 21.13 (8.62) 17.71 (6.86) | 24.14 (17.05) 17,79 (6,08) | −4.44 (−21%) | −6.35 (−26.3%) | 0.51 |
Barthel Index (0–100) | 86.94 (15.06) 90.56 (9.84) | 86.56 (11.21) 89.69 (8.65) | + 3.61 (+ 4.2%) | + 3.13 (+ 3.6%) | 0.56 |